Page 582 - ACCCN's Critical Care Nursing
P. 582

Management of Shock 559



               Learning activities, Continued
               1.  What assessments are important to obtain appropriate infor-  Reflect  on  a  case  of  a  patient  with  shock  that  you  have  been
                  mation for a patient presenting with signs of hypoperfusion?  involved in, and consider the following:
               2.  What systems are in place where you work to ensure adequate   5.  What elements of care or ‘care bundles’ were effective in man-
                  processes are in place to assess patients presenting in shock?  aging symptoms of shock?
               3.  How could the patient in the case study have been managed   6.  What  processes  would  you  use  in  future  to  syste-
                  differently?                                       matically  assess,  manage  and  evaluate  care  of  a  patient  in
               4.  What are the clinical escalation processes in the facilities you   shock?
                  have worked in?



             ONLINE RESOURCES                                      15.  Hubbard  WJ,  Bland  KI,  Chaudry  IH.  The  role  of  the  mitochondrion  in
                                                                     trauma and shock. Shock 2004; 22(5): 395–402.
             American Heart Association, http://www.heart.org/HEARTORG/  16.  Al-Khafaji AH, Sharma S, Eschun G, Franklin C, Talavera F et al.Multisystem
             Anaphylaxis Australia, www.allergyfacts.org.au/         organ  failure  of  sepsis.  2004.  [Cited  Aug  2004].  Available  from:
             Australian  Commission  on  Safety  and  Quality  in  Healthcare,  http://www.  http://www.emedicine.com/med/topic3372.htm.
               safetyandquality.gov.au/internet/safety/publishing.nsf/Content/home  17.  Fortin C, McDonald P, Fulop T, Lesur O. Sepsis, leukocytes, and nitric oxide
             Cardiac Society of Australia and New Zealand, http://www.csanz.edu.au/Home/  (NO): An intricate affair. Shock 2010; 33(4): 344–52.
               tabid/62/Default.aspx                               18.  Cheatham M. The Holy Grail of shock resuscitation. Crit Care Med 2005;
             Clinical  Excellence  Commission:  Between  the  flags,  http://www.cec.health.  33(11): 2691–2.
               nsw.gov.au/programs/between-the-flags.html          19.  Casserly B, Read R, Levy M. Hemodynamic monitoring in sepsis. Crit Care
             National Blood Authority Australia, www.nba.gov.au      Clinics 2009; 25(4): 803–23.
             Sepsis, http://www.ihi.org/ihi/topics/criticalcare/sepsis  20.  Wagner F, Baumgart K, Simkova V, Georgieff M, Radermacher P, Calzia E.
             Spinal cord injury network, https://spinalnetwork.org.au/  Year  in  review  2007:  Critical  Care:  shock.  Critical  Care  2008;  12(5):
             Surviving sepsis, www.survivingsepsis.org/              227.
             World Allergy Organisation, http://www.worldallergy.org/index.php  21.  Mikkelsen ME, Miltiades AN, Gaieski DF et al. Serum lactate is associated
                                                                     with mortality in severe sepsis independent of organ failure and shock. Crit
                                                                     Care Med 2009; 37(5): 1670–77.
             FURTHER READING                                       22.  Nguyen HB, Rivers EP, Knoblich BP, et al. Early lactate clearance is associated
                                                                     with  improved  outcome  in  severe  sepsis  and  septic  shock.  Crit  Care  Med
             Manji RA, Wood KE, Kumar A. The history and evolution of circulatory shock.   2004; 32(8): 1637–42.
               Critical Care Clinics 2009; 25(1): 1–29             23.  Fishel RS, Are C, Barbul A. Vessel injury and capillary leak. Crit Care Med
             Australian  Commission  on  Safety  and  Quality  in  Healthcare.  Recognising  and   2003; 31(8Suppl): S502–11.
               responding to clinical deterioration: Background Paper, June 2008. Available from:   24.  Sherwood ER, Toliver-Kinsky T. Mechanisms of the inflammatory response.
               http://www.safetyandquality.gov.au/internet/safety/publishing.nsf/Content/  Best Pract Res Clin Anaesth 2004; 18(3): 385–405.
               AB9325A491E10CF1CA257483000C9AC4/$File/BackgroundPaper-2009.pdf
                                                                   25.  Leach  R,  Treacher  D.  Oxygen  transport-2.  Tissue  hypoxia.  BMJ  1998;
                                                                     317(7169):1370–73.
             REFERENCES                                            26.  Adams K. Hemodynamic assessment: the physiologic basis for turning data
                                                                     into clinical information. AACN Clinical Issues: Advanced Practice in Acute and
              1.  Adams  F.  The  book  of  prognostics,  by  Hippocrates.  In:  eBooks@Adelaide   Critical Care 2004; 15(4): 534–46.
                University   of   Adelaide   Library;   2007.   Available   from:   http://  27.  Moshkovitz Y, Kaluski E, Milo O, Vered Z, Cotter G. Recent developments in
                ebooks.adelaide.edu.au/h/hippocrates/prognostics/    cardiac output determination by bioimpedance: comparison with invasive
              2.  Rice TW, Bernard BG. Drotrecogin alfa (activated) for the treatment of severe   cardiac output and potential cardiovascular applications. Curr Opin Cardiol
                sepsis and septic shock. Am J Med Sci 2004; 328(4): 205–14.  2004; 19(3): 229–37.
              3.  Kelley D. Hypovolemic shock: an overview. Crit Care Nurs Q 2005; 28(1):   28.  Levin  PD,  Sprung  CL.  Another  point  of  view:  no  swan  song  for  the  pul-
                2–19.                                                monary artery catheter. Crit Care Med 2005; 33(5): 1123–4.
              4.  Bridges EJ, Duke S. Cardiovascular aspects of septic shock: pathophysiology,   29.  Boettger S, Pavlovic D, Grundling M, Wendt M, Hung O et al. Comparison
                monitoring, and treatment. Crit Care Nurs 2005; 25(2): 14–24.  of  arterial  pressure  cardiac  output  monitoring  with  transpulmonary  ther-
              5.  Manji  RA,  Wood  KE,  Kumar  A.  The  history  and  evolution  of  circulatory   modilution in septic patients. Med Sci Monitor 2010; 16(3):PR1–7.
                shock. Critical Care Clinics 2009; 25(1): 1–29.    30.  Treacher D, Harvey C, Bradley R. Can cardiac output be assessed clinically with
              6.  Barbee  R,  Reynolds  P,  Ward  K.  Assessing  shock  resuscitation  strategies  by   sufficient accuracy to be of value in patient management? Comparison with thermo-
                oxygen debit repayment. Shock 2010; 33(2): 113–22.   dilution  in  Intensive  Care  Unit  patients.  London:  The  Intensive  Care  Unit,
              7.  Kellum JA. Use of vasopressor agents in critically ill patients. Curr Opin Crit   UMDS, St Thomas’ Hospital; 2006.
                Care 2002; 8(3): 236–41.                           31.  Boyle M, Steel L, Flynn G, Murgo M, Nicholson L et al. Assessment of the
              8.  Strehlow  MC.  Early  identification  of  shock  in  critically  ill  patients.  Emerg   clinical utility of an ultrasonic monitor of cardiac output (the USCOM) and
                Med Clin N Am 2010; 28(1): 57–66.                    agreement with thermodilution measurement. Crit Care Resusc 2009; 11(3):
              9.  Kinney  M,  Dunbar  S,  Brooks-Brunn  J,  Molter  N,  Vitello-Cicciu  J.  AACN’s   198–203.
                clinical reference for critical care nursing. St Louis: Mosby; 1998.  32.  Godje O, Hoke K, Goetz AE, Felbinger TW, Reuter DA et al. Reliability of a
              10.  Vallet B, Weil E, Lebuffe G. Resuscitation from circulatory shock: an approach   new  algorithm  for  continuous  cardiac  output  determination  by  pulse-
                based on oxygen-derived parameters. Berlin; Springer-Verlag; 2005.  contour  analysis  during  hemodynamic  instability.  Crit  Care  Med  2002;
              11.  Hameed  SM,  Aird  WC,  Cohn  SM.  Oxygen  delivery.  Crit  Care  Med  2003;   30(1): 52–8.
                31(12Suppl): 5658–67.                              33.  Shah MR, Hasselblad V, Stevenson LW et al. Impact of the pulmonary artery
              12.  ACCCN.  National  Advanced  Life  Support  Education  Package.  Melbourne:   catheter in critically ill patients: meta-analysis of randomized clinical trials.
                Cambridge Press; 2004.                               JAMA 2005; 294(13): 1664–70.
              13.  Brealey D, Brand M, Hargreaves I, Heales S, Land J, et al. Association between   34.  Harvey S, Welch C, Harrison D, Rowan K, Singer M. Post hoc insights from
                mitochondrial dysfunction and severity and outcome of septic shock. Lancet   PAC-Man: the UK pulmonary artery catheter trial. Crit Care Med 2008; 36(6):
                2002; 360(9328): 219–23.                             1714–21.
              14.  Trager K, DeBacker D, Radermacher P. Metabolic alterations in sepsis and   35.  Rivers  E,  Nguyen  B,  Havstad  S  et  al.  Early  goal-directed  therapy  in  the
                vasoactive  drug-related  metabolic  effects.  Curr  Opin  Crit  Care  2003;  9(4):   treatment  of  severe  sepsis  and  septic  shock.  N  Eng  J  Med  2001;  345(19):
                271–8.                                               1368–77.
   577   578   579   580   581   582   583   584   585   586   587